Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | — | 3.3T | 3.3T | 3.1T |
Cost of revenue | 1.0T | 1.1T | 1.0T | 933.5B |
Gross profit | — | 2.2T | 2.3T | 2.2T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | 52.3B | 91.9B | 84.7B |
Other operating expenses | 10.7B | -978M | 93.9B | -2.9B |
Operating income | 1.9T | 1.9T | 1.9T | 1.9T |
Non operating interest income | ||||
Income | — | 36.0B | 18.5B | 21.6B |
Expense | — | 850.8B | 818.0B | 700.4B |
Other income expense | — | — | — | — |
Pretax income | 780.3B | 906.9B | 849.7B | 923.1B |
Tax provision | — | 19.9B | -6.1B | 103.7B |
Net income | 805.0B | 887.0B | 855.8B | 819.4B |
Basic EPS | 16 | — | — | — |
Diluted EPS | — | — | — | — |
Basic average shares | — | — | — | — |
Diluted average shares | 49.8B | — | — | — |
EBITDA | 1.6T | 1.8T | 1.7T | 1.6T |
Net income from continuing op. | — | — | — | — |
Minority interests | — | 1.2B | -13.6B | -11.7B |
Preferred stock dividends | 0 | 0 | 0 | 0 |